The products in our Energy and Longevity collection share a difficulty that has nothing to do with how well they are made. The thing they are bought for, a longer or better life, is close to impossible to measure in a person over the weeks a trial runs. So researchers measure a stand-in: a number in the blood, a reading off an artery. That number can move while the life it is meant to represent stays exactly where it was.
That gap sits underneath this whole category, and it is worth understanding before you spend anything. Here is what the human research actually shows for each compound, and where it runs out.
Why are longevity supplements so hard to judge?
Testing whether something extends life means following people for decades. No supplement trial does that, so trials measure a surrogate marker instead: blood NAD, insulin sensitivity, how well an artery widens. These are reasonable proxies for processes that change with age. A moved proxy is still a hypothesis about longevity, not a demonstration of one.
Some of the interest is well founded. NAD-related compounds fall in human tissue as we age, which is one reason raising them looks appealing on paper. Appealing on paper is roughly where the human outcome evidence stops. When you read that a longevity supplement "works", the useful next question is what moved, in whom, and whether that thing is a biomarker or a life.
What does the human evidence for NMN actually show?
NMN is a precursor the body uses to rebuild NAD, so it is one of the more testable ideas in this category. The clearest positive human trial gives 250 mg daily to thirteen postmenopausal women who had overweight or obesity and prediabetes, over ten weeks. It reported improved insulin sensitivity in skeletal muscle, while several other metabolic measures did not shift. That is a real result in a narrow group, and it does not carry over to a healthy adult who simply wants more energy.
Pool the trials and the picture gets more restrained. A systematic review of eight randomised trials, covering 342 mostly middle-aged and older adults, found no significant benefit for fasting glucose, fasting insulin, glycated haemoglobin, insulin resistance or lipids. A separate meta-analysis reported the cleanest version of the whole problem: NMN raised blood NAD levels, and did not establish a broad metabolic benefit. The biomarker it targets went up, and the outcomes people care about stayed unproven.
Two of our products sit here. NAD+ Gold is a lower-dose liquid with added betaine, and Super NMN 500 mg is a higher-dose single-ingredient capsule. The tenfold difference in NMN between them does not name a winner, because no trial has compared these formats for any outcome that matters to a buyer. Whichever you pick, the human evidence is the same, and it is thin: a few small trials, a raised biomarker, and no data on longer human life.
Does MitoQ do more than ordinary CoQ10?
MitoQ is built to accumulate inside mitochondria, which is a genuinely different design from standard CoQ10. Much of the supporting work is animal research, so the human side rests on a small number of trials. The most cited gives 20 mg daily to twenty adults aged 60 to 79 who already had impaired blood-vessel function, over six weeks. Against placebo, one measure of how well the brachial artery widened improved.
Read who that trial was about. These were older adults with existing vascular impairment, taking twice the 10 mg daily amount on the products stocked here. Sustained energy, exercise recovery and lifespan were not measured and are not shown. The targeting mechanism is real, and it does not make MitoQ a stronger CoQ10 on a milligram-for-milligram scale, because the molecules, doses and studies are not the same.
MitoQ Pure isolates the compound on its own. MitoQ + Curcumin adds a curcumin to it. The two are alternatives rather than a pair to stack, since taking both just doubles the MitoQ. No human trial tests the finished curcumin combination for a longevity or energy outcome.
Is PQQ or resveratrol worth adding?
PQQ appears in a lot of laboratory work on mitochondrial signalling, including cell studies where it prompts the growth of new mitochondria. The human literature is much smaller and mixes different formulations and endpoints, so the striking cell findings should not be read as an established effect in people. The ONE pairs PQQ with CoQ10, resveratrol, tocotrienols and a proprietary herbal blend, which suits someone deliberately choosing breadth over a single studied active, at the cost of knowing what each part is doing.
Resveratrol has the largest literature of anything here and the least to show for it. A systematic review mapped close to 200 clinical studies across two dozen uses and found no conclusive clinical evidence to recommend it in a healthcare setting, alongside a call for larger, better trials. Oral resveratrol is also broken down fast in the body, which complicates every dose. Resveratrol Healthy Ageing combines it with turmeric and quercetin, and that formula has not been shown to change resveratrol's exposure or any clinical outcome, and there is no clear group the human evidence speaks to yet.
So, what does the evidence support?
What holds up across this collection is narrow and worth stating plainly. In selected groups, often people who were unwell to begin with, a biomarker moved over a short trial: blood NAD rose, insulin sensitivity improved in a small sample, an artery widened a little better. None of these trials followed anyone long enough to show a longer or better life, and none was run in healthy adults hoping for more day-to-day energy.
That makes these compounds considered bets on plausible biology, not proven interventions. A bet can be reasonable, and it is a fairer description than the marketing around the category usually allows. If you buy one, buy it on that understanding, start with the narrowest formula that matches the question you are actually asking, and watch that a moved biomarker is not quietly standing in for a result you were never promised. Sleep, food, movement and managing any health condition carry far broader evidence than anything on this page.
References
- Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 2012;7(7):e42357. DOI: 10.1371/journal.pone.0042357 (PMID: 22848760)
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 2021;372(6547):1224-1229. DOI: 10.1126/science.abe9985 (PMID: 33888596)
- Chen F, Zhou D, Kong APS, et al. Effects of nicotinamide mononucleotide on glucose and lipid metabolism in adults: a systematic review and meta-analysis of randomised controlled trials. Current Diabetes Reports, 2025;25(1):4. DOI: 10.1007/s11892-024-01557-z (PMID: 39531138)
- Zhang J, Poon ETC, Wong SHS. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2025;65(22):4382-4400. DOI: 10.1080/10408398.2024.2387324 (PMID: 39116016)
- Smith RAJ, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences, 2010;1201:96-103. DOI: 10.1111/j.1749-6632.2010.05627.x (PMID: 20649545)
- Rossman MJ, Santos-Parker JR, Steward CAC, et al. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension, 2018;71(6):1056-1063. DOI: 10.1161/HYPERTENSIONAHA.117.10787 (PMID: 29661838)
- Chowanadisai W, Bauerly KA, Tchaparian E, et al. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. Journal of Biological Chemistry, 2010;285(1):142-152. DOI: 10.1074/jbc.M109.030130 (PMID: 19861415)
- Brown K, Theofanous D, Britton RG, et al. Resveratrol for the management of human health: how far have we come? A systematic review of resveratrol clinical trials to highlight gaps and opportunities. International Journal of Molecular Sciences, 2024;25(2):747. DOI: 10.3390/ijms25020747 (PMID: 38255828)
This article describes findings from published research for general educational purposes. It is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease. If you take prescription medication or have a health condition, consult a qualified healthcare professional before adding a supplement.